Cardiovascular Diseases
Conditions
Interventions
This is a randomized clinical trial and single-center. Participants will be divided into three groups: (1) without pharmaceutical care both at hospital discharge and in the post-discharge period (usua
(2) with pharmaceutical care at hospital discharge and without pharmaceutical care in the post-discharge period (intervention A)
(3) with pharmaceutical care at hospital discharge and also in a pharmaceutical consultation in the post-discharge period (intervention B). Discharge pharmaceutical care will consist of medication rec
(b) age between 51 and 75 years
(c) age equal to or greater than 76 years, and will use variable blocks, whose order and size will be defined by drawing lots and hidden by opaque envelopes. The preparation of the envelopes will be c
F02.784.176
N02.421.450.500.500
N05.300.150.800.500.600.500
E02.319.529
Sponsors
Leonardo Coutinho Ribeiro
Empresa Brasileira de Serviços Hospitalares (EBSERH)
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over 18 years of age; both sexes, admitted to the Cardiology Ward, who entered the institution under study on an emergency basis, agreed to sign the free and informed consent form (FICT) and voice recording term
Exclusion criteria
Exclusion criteria: Electively admitted patients; no contact phone; without autonomy to self-administer, without assistance from others, medication and who are not accompanied by a family member or caregiver who can provide necessary and reliable information about their treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the evolution of the general health status of patients up to 30 days after hospital discharge by comparing the results between the 3 different research groups, based on the following indicators: patient's degree of anxiety/depression, using the Hospital Anxiety Scale and Depression (HADS); number of undesirable events (mortality rates, need for unplanned medical care, recurrence of hospitalization) and medical opinion prepared using data collection instruments developed in this research for such purposes. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate the evolution of favorable conditions for optimizing the drug treatment of patients up to 30 days after hospital discharge by comparing the results between the 3 different research groups, based on the following indicators: adherence to pharmacotherapy, through the Pharmacotherapy Adherence Scale and Replacement Medicines (ARMS); no. and types of pharmacotherapy problems and discrepancies between the discharge prescription and the form of medication use reported by users through the data collection instruments developed in this research for such purposes.;To evaluate the pharmacist's clinical activity based on the user's degree of satisfaction using the Brazilian version of the instrument consúltenos de información al alta hospitalia; and in the number of interventions and the medical team's rate of acceptability of pharmaceutical interventions accounted for through registration in a data matrix. | — |
Countries
Brazil
Contacts
Public ContactLeonardo Ribeiro
Hospital Universitário Cassiano Antonio Moraes (HUCAM)/Universidade Federal do Espírito Santo (UFES)
Outcome results
None listed